Jacobs & Co
- SEC CIK
- 0001055544
- Latest filing
- Jul 8, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 61,621
- Value
- $15.5M
- % of portfolio
- 1.3%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 61,621 | $15.5M | 1.3% | +425+0.7% | Added | Holders |
| Q1 2026 | 61,196 | $13.3M | 1.3% | +2,594+4.4% | Added | Holders |
| Q4 2025 | 58,602 | $13.4M | 1.3% | −1,498−2.5% | Reduced | Holders |
| Q3 2025 | 60,100 | $13.9M | 1.3% | −1,539−2.5% | Reduced | Holders |
| Q2 2025 | 61,639 | $11.4M | 1.1% | +1,211+2.0% | Added | Holders |
| Q1 2025 | 60,428 | $12.7M | 1.3% | −186−0.3% | Reduced | Holders |
| Q4 2024 | 60,614 | $10.8M | 1.1% | −312−0.5% | Reduced | Holders |
| Q3 2024 | 60,926 | $12.0M | 1.2% | −919−1.5% | Reduced | Holders |
| Q2 2024 | 61,845 | $10.6M | 1.1% | +649+1.1% | Added | Holders |
| Q1 2024 | 61,196 | $11.1M | 1.2% | −1,737−2.8% | Reduced | Holders |
| Q4 2023 | 62,933 | $9.75M | 1.1% | −292−0.5% | Reduced | Holders |
| Q3 2023 | 63,225 | $9.42M | 1.2% | −963−1.5% | Reduced | Holders |
| Q2 2023 | 64,188 | $8.65M | 1.0% | −7,772−10.8% | Reduced | Holders |
| Q1 2023 | 71,960 | $11.5M | 1.4% | −2,417−3.2% | Reduced | Holders |
| Q4 2022 | 74,377 | $12.0M | 1.6% | +956+1.3% | Added | Holders |
| Q3 2022 | 73,421 | $9.85M | 1.4% | −880−1.2% | Reduced | Holders |
| Q2 2022 | 74,301 | $11.4M | 1.5% | −1,761−2.3% | Reduced | Holders |
| Q1 2022 | 76,062 | $12.3M | 1.4% | −1,527−2.0% | Reduced | Holders |
| Q4 2021 | 77,589 | $10.5M | 1.1% | +2,587+3.4% | Added | Holders |
| Q3 2021 | 75,002 | $8.09M | 0.9% | +4,513+6.4% | Added | Holders |
| Q2 2021 | 70,489 | $7.94M | 0.9% | −1,980−2.7% | Reduced | Holders |
| Q1 2021 | 72,469 | $7.84M | 1.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.